Evidence map›Paper›PMID 31578955›Full record

ReviewThe lancet. HIV2019

Conditional economic incentives to improve HIV prevention and treatment in low-income and middle-income countries.

Omar Galárraga, Sandra G Sosa-Rubí

Abstract readReview
In one paragraph

Review in The lancet. HIV, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Incentivizing adherence to pre-exposure prophylaxis for HIV prevention: a randomized pilot trial among male sex workers in Mexico.The European journal of health economics : HEPAC : health economics in prevention and care · 2025
    Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Omar GalárragaBrown University School of Public Health, Providence, RI, USA.
Sandra G Sosa-RubíNational Institute of Public Health, Cuernavaca, Mexico. Electronic address: sandra.sosa.rubi@gmail.com.

Funding

Translational ScienceP30AI042853 · NIAID · MIRIAM HOSPITAL · PI CURT G BECKWITH, DEBBIE M. CHENG · 1998 to 2026
$51.7M
Science/Technical CoreP2CHD041020 · NICHD · BROWN UNIVERSITY · PI ZHENCHAO QIAN · 2016 to 2026
$7.6M
PrEP Seguro: Antiretrovial-based HIV prevention among men at high risk in MexicoR34MH114664 · NIMH · BROWN UNIVERSITY · PI GALARRAGA, OMAR · 2017 to 2019
$638k
Conditional Economic Incentives for Improving Adolescent Adherence to HIV TreatmentR21AI118393 · NIAID · BROWN UNIVERSITY · PI GALARRAGA, OMAR, HOARE, JACQUELINE · 2016 to 2017
$404k
Using Behavioral Economics to Promote Exercise among Inactive Overweight AdultsR03CA188473 · NCI · BROWN UNIVERSITY · PI GALARRAGA, OMAR, WILLIAMS, DAVID M · 2015 to 2016
$163k
NCI NIH HHS R03 CA188473NIAID NIH HHS P30 AI042853NIAID NIH HHS R21 AI118393NICHD NIH HHS P2C HD041020NIMH NIH HHS R34 MH114664
6 · The paper itself

Abstract

New and innovative approaches are needed to improve the prevention, diagnosis, and treatment of HIV in low-income and middle-income countries. Several trials use conditional economic incentives (CEIs) to improve HIV outcomes. Most CEI interventions use a traditional economic theory approach, although some interventions incorporate behavioural economics, which combines traditional economics with insights from psychology. Incentive interventions that are appropriately implemented can increase HIV testing rates and voluntary male circumcision, and they can improve other HIV prevention and treatment outcomes in certain settings in the short term. More research is needed to uncover theory-based mechanisms that increase the duration of incentive effects and provide strategies for susceptible individuals, which will help to address common constraints and biases that can influence health-related decisions.

Indexed as

Anti-HIV AgentsDeveloping CountriesHIV InfectionsHumansPovertyAnti-HIV Agents

Identifiers

PMID31578955
PMCPMC7725432

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.